Literature DB >> 15452522

A shift from demerol (meperidine) to dilaudid (hydromorphone) improves pain control and decreases admissions for patients in sickle cell crisis.

Kathryn M Perlman1, Suzanne Myers-Phariss, Jeremy C Rhodes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15452522     DOI: 10.1016/j.jen.2004.06.016

Source DB:  PubMed          Journal:  J Emerg Nurs        ISSN: 0099-1767            Impact factor:   1.836


× No keyword cloud information.
  2 in total

1.  Effects of Patient Controlled Analgesia Hydromorphone during Acute Painful Episodes in Adolescents with Sickle Cell Disease: A Pilot Study.

Authors:  Eufemia Jacob; Marilyn Hockenberry; Brigitta U Mueller
Journal:  J Pain Manag       Date:  2008-01-01

2.  Analgesic Response to Morphine in Children with Sickle Cell Disease: A Pilot Study.

Authors:  Eufemia Jacob; Marilyn Hockenberry; Brigitta U Mueller; Thomas D Coates; Lonnie Zeltzer
Journal:  J Pain Manag       Date:  2008
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.